Get the Stockscreener App
0.6613
8.91%
-0.0647
After Hours:
.66
-0.0013
-0.20%
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health files patent for allergy inflammation treatment - MSN
Cosmos Health : Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow - Marketscreener.com
Major European Bank Backs Cosmos Health with €2.2M Strategic Financing Deal - StockTitan
Cosmos Health files patent for allergy inflammation treatment By Investing.com - Investing.com UK
Cosmos Health Files AI-Powered Patent for Revolutionary Allergy Treatment - StockTitan
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. Enters into Patent and Technology License Agreement with DocPharma Single SA. (Greece) - Defense World
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait - Lelezard
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 By Investing.com - Investing.com South Africa
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Health expands distribution of Avian Influenza kits By Investing.com - Investing.com UK
Cosmos Health Expands Virax PCR Kit Distribution to Saudi Arabia, UAE in Major Gulf Growth - StockTitan
Fast-paced Momentum Stock Cosmos Health Inc. (COSM) Is Still Trading at a Bargain - Yahoo Canada Finance
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million - Marketscreener.com
Cosmos Health secures exclusive cancer patent license By Investing.com - Investing.com Australia
Cosmos Health secures exclusive cancer patent license - Investing.com
Cosmos Health secures rights to two anticancer drugs By Investing.com - Investing.com Australia
Cosmos Health secures rights to two anticancer drugs - Investing.com
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cance - PharmiWeb.com
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Pro - News Channel Nebraska
Cosmos Health CEO Shows Conviction With $425,000 Share Purchase, Total Investment Tops $17M - StockTitan
Cosmos Health CEO acquires $25,000 in stock through debt exchange - MSN
Cosmos Health CEO acquires $25,000 in stock through debt exchange By Investing.com - Investing.com South Africa
Head-To-Head Comparison: Aceto (OTCMKTS:ACETQ) versus Cosmos Health (NASDAQ:COSM) - Defense World
Aceto (OTCMKTS:ACETQ) versus Cosmos Health (NASDAQ:COSM) Financial Comparison - Defense World
Cosmos health CEO Siokas acquires shares in $40,000 debt exchange - MSN
Market Might Still Lack Some Conviction On Cosmos Health Inc. (NASDAQ:COSM) Even After 31% Share Price Boost - Simply Wall St
Cosmos health CEO Siokas acquires shares in $40,000 debt exchange By Investing.com - Investing.com Australia
Cosmos Health CEO Grigorios Siokas acquires $50,000 in stock - MSN
Cosmos Health CEO Grigorios Siokas acquires $50,000 in stock By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires shares worth $60,000 By Investing.com - Investing.com Australia
Cosmos Health CEO acquires shares worth $60,000 - Investing.com India
Cosmos Health CEO acquires $100,000 in stock via debt exchange By Investing.com - Investing.com Australia
Cosmos Health CEO acquires $100,000 in stock via debt exchange - Investing.com India
Cosmos Health secures exclusive distribution agreement with Virax Biolabs - Yahoo Finance
3.42%
2.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):